Shah VH - Search Results

1

Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.

Arab JP, Martin-Mateos RM, Shah VH. Arab JP, et al. Among authors: shah vh. Hepatol Int. 2018 Feb;12(Suppl 1):24-33. doi: 10.1007/s12072-017-9798-x. Epub 2017 May 26. Hepatol Int. 2018. PMID: 28550391 Free PMC article.

2

Pathogenesis, diagnosis, and treatment of alcoholic liver disease.

Menon KV, Gores GJ, Shah VH. Menon KV, et al. Among authors: shah vh. Mayo Clin Proc. 2001 Oct;76(10):1021-9. doi: 10.4065/76.10.1021. Mayo Clin Proc. 2001. PMID: 11605686 Review.

3

Nitric oxide and portal hypertension: interface of vasoreactivity and angiogenesis.

Langer DA, Shah VH. Langer DA, et al. Among authors: shah vh. J Hepatol. 2006 Jan;44(1):209-16. doi: 10.1016/j.jhep.2005.10.004. Epub 2005 Nov 4. J Hepatol. 2006. PMID: 16297493 Review. No abstract available.

4

Management of portal hypertension.

Shah VH, Kamath P. Shah VH, et al. Postgrad Med. 2006 Sep-Oct;119(3):14-8. doi: 10.1080/00325481.2006.11446045. Postgrad Med. 2006. PMID: 17128640 Review.

5

Molecular mechanisms of increased intrahepatic resistance in portal hypertension.

Shah V. Shah V. J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S259-61. doi: 10.1097/MCG.0b013e318150d0e1. J Clin Gastroenterol. 2007. PMID: 17975474 Review.

6

Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis.

Huebert RC, Vasdev MM, Shergill U, Das A, Huang BQ, Charlton MR, LaRusso NF, Shah VH. Huebert RC, et al. Among authors: shah vh. Hepatology. 2010 Jul;52(1):238-48. doi: 10.1002/hep.23628. Hepatology. 2010. PMID: 20578142 Free PMC article.

7

Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

Thabut D, Shah V. Thabut D, et al. J Hepatol. 2010 Nov;53(5):976-80. doi: 10.1016/j.jhep.2010.07.004. Epub 2010 Jul 24. J Hepatol. 2010. PMID: 20800926 Free article. Review.

8

Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis.

Thabut D, Routray C, Lomberk G, Shergill U, Glaser K, Huebert R, Patel L, Masyuk T, Blechacz B, Vercnocke A, Ritman E, Ehman R, Urrutia R, Shah V. Thabut D, et al. Hepatology. 2011 Aug;54(2):573-85. doi: 10.1002/hep.24427. Epub 2011 Jun 26. Hepatology. 2011. PMID: 21567441 Free PMC article.

9

Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs.

Huebert RC, Jagavelu K, Hendrickson HI, Vasdev MM, Arab JP, Splinter PL, Trussoni CE, Larusso NF, Shah VH. Huebert RC, et al. Among authors: shah vh. Am J Pathol. 2011 Oct;179(4):1851-60. doi: 10.1016/j.ajpath.2011.06.045. Epub 2011 Aug 18. Am J Pathol. 2011. PMID: 21854740 Free PMC article.

10

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice.

Zhu Q, Zou L, Jagavelu K, Simonetto DA, Huebert RC, Jiang ZD, DuPont HL, Shah VH. Zhu Q, et al. Among authors: shah vh. J Hepatol. 2012 Apr;56(4):893-9. doi: 10.1016/j.jhep.2011.11.013. Epub 2011 Dec 13. J Hepatol. 2012. PMID: 22173161 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters